Alexandria Real Estate Equities, Inc. (NYSE: ARE) is a specialized real estate investment trust (REIT) that focuses on developing and operating life science and technology campuses. Founded in 1994, the company pioneered the concept of clustering purpose-built laboratory and office spaces near major academic and medical research institutions. Its business model centers on acquiring, developing, and leasing highly specialized properties that meet the complex infrastructure, power, ventilation, and safety requirements of biotechnology, pharmaceutical, and institutional research tenants.
The company generates revenue primarily through long-term lease agreements with a diverse tenant base that includes multinational pharmaceutical companies, public and private biotechnology firms, life science product and service companies, and academic institutions. Alexandria's geographic footprint is concentrated in the top AAA innovation clusters in the United States, specifically Greater Boston, the San Francisco Bay Area, San Diego, Seattle, the Maryland region, the Research Triangle in North Carolina, and New York City.
In addition to its core real estate operations, the company operates Alexandria Venture Investments, a strategic venture capital platform that invests in early-stage and growth-stage life science and agtech companies. This dual approach not only provides investment returns but also helps cultivate future tenants for its real estate portfolio. Alexandria's competitive position is strengthened by its first-mover advantage, deep expertise in life science facility requirements, and strong relationships within the biopharma ecosystem. Because its buildings require specialized design and support critical laboratory research, its properties are highly resilient and cater to tenants whose work cannot be transitioned to conventional office spaces or remote environments.
